4 completed, 4 unknown, 2 recruiting, 1 not yet recruiting. 11 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 4, Unknown 4, Recruiting 2, Not yet recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Advanced Gastric Carcinoma: new trials by email Literature Review of Advanced Gastric Carcinoma trials Research Report on Advanced Gastric Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer | Phase 2 / Phase 3 | Recruiting | Ukrainian Society of Clinical Oncology | 150 | 2025-03-25 | 2025-05-06 |
| SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer SHR-A1811 & Apartinib - Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Yunpeng Liu | 28 | 2024-12-01 | 2024-10-30 |
| At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment - Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 220 | 2023-09-21 | 2026-11-06 |
| RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer RC48+AK105+cisplatin - Advanced Gastric Carcinoma, HER2-positive Gastric Cancer | Phase 2 | Unknown | Henan Cancer Hospital | 40 | 2022-05-07 | 2022-04-06 |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 IMM2902 - Advanced Solid Tumor, Advanced Lung Cancer | Phase 1 / Phase 2 | Unknown | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 105 | 2022-02-15 | 2023-04-10 |
| iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Irinotecan, Oxaliplatin, TAS 102 (Trifluridine/Tipiracil) - Gastroesophageal Junction Adenocarcinoma, Advanced Gastric Carcinoma | Phase 2 | Completed | AHS Cancer Control Alberta | 7 | 2021-10-27 | 2024-06-14 |
| Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma camrelizumab, Apatinib Mesylate - Advanced Gastric Carcinoma | Phase 2 | Unknown | Henan Cancer Hospital | 20 | 2021-04-28 | 2021-07-01 |
| Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) Atezolizumab + Ipatasertib, Atezolizumab + Bevacizumab - Gastric Adenocarcinoma, Metastatic Gastric Cancer | Phase 2 | Completed | Hospices Civils de Lyon | 54 | 2021-03-19 | 2026-06-09 |
| Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer. Trastuzumab, Oxaliplatin, Capecitabine - Advanced Gastric Carcinoma | Phase 2 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 60 | 2021-03-01 | 2023-08-18 |
| Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer paclitaxel liposome - Advanced Gastric Carcinoma | Phase 2 | Unknown | Peking University | 30 | 2013-12-01 | 2014-06-13 |
| A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma pemetrexed, oxaliplatin - Advanced Gastric Carcinoma | Phase 2 | Completed | Eli Lilly and Company | 43 | 2004-05-01 | 2007-01-26 |
Stomach Neoplasms (2) · Adenocarcinoma (1) · Gastrointestinal Neoplasms (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Stomach Diseases (2) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Carcinoma (1) · Cardiovascular Diseases (1) · Gastrointestinal Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1)
Oxaliplatin (4) · Bevacizumab (1) · Capecitabine (1) · Docetaxel (1) · Fluorouracil (1) · Home Care Services (1) · House Calls (1) · Irinotecan (1) · Leucovorin (1) · Pemetrexed (1) · Trastuzumab (1) · Trifluridine (1) · apatinib (1) · atezolizumab (1) · camrelizumab (1)
Henan Cancer Hospital (2) · AHS Cancer Control Alberta (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Eli Lilly and Company (1) · Hospices Civils de Lyon (1) · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1) · Mayo Clinic (1) · Peking University (1) · Ukrainian Society of Clinical Oncology (1) · Yunpeng Liu (1)
China (5) · Bangladesh (1) · Canada (1) · France (1) · Italy (1) · Lithuania (1) · Ukraine (1) · United States (1)
Hatim Karachiwala, MD (1) · Jiafu Ji, M.D. (1) · Mykyta Pepenin, MD (1) · Quanli Gao, Dr (1) · Roxana S. Dronca, MD (1) · Sarwar Alam, MBBS, Mphil (1) · Ying Liu (1)